| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 326.95B | 339.49B | 324.06B | 307.90B | 304.57B | 298.28B |
| Gross Profit | 90.93B | 103.47B | 86.77B | 76.71B | 79.57B | 86.98B |
| EBITDA | 45.97B | 50.30B | 45.70B | 34.49B | 34.38B | 41.37B |
| Net Income | 27.28B | 29.65B | 25.82B | 17.14B | 16.60B | 21.00B |
Balance Sheet | ||||||
| Total Assets | 553.39B | 581.11B | 559.56B | 520.43B | 495.12B | 498.81B |
| Cash, Cash Equivalents and Short-Term Investments | 57.93B | 68.24B | 63.75B | 71.02B | 76.48B | 80.06B |
| Total Debt | 20.85B | 0.00 | 2.98B | 1.60B | 1.44B | 1.15B |
| Total Liabilities | 101.83B | 113.42B | 111.71B | 96.85B | 100.36B | 105.59B |
| Stockholders Equity | 449.29B | 465.27B | 445.65B | 421.75B | 393.23B | 391.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.33B | -5.18B | 4.55B | 935.00M | 24.48B |
| Operating Cash Flow | 0.00 | 24.95B | 26.52B | 19.11B | 15.30B | 30.13B |
| Investing Cash Flow | 0.00 | -9.28B | -32.50B | -21.71B | -25.01B | 7.63B |
| Financing Cash Flow | 0.00 | -11.19B | -7.12B | -5.82B | -6.60B | -4.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥95.00B | 12.01 | ― | 1.71% | 5.83% | 28.79% | |
72 Outperform | ¥311.68B | 10.39 | 7.48% | 1.79% | 4.76% | 15.92% | |
70 Outperform | ¥942.11B | 17.91 | 5.45% | 1.30% | 4.46% | 21.24% | |
70 Outperform | ¥31.22B | 7.06 | ― | 1.67% | 4.43% | 77.99% | |
69 Neutral | ¥681.32B | 11.71 | 6.38% | 1.03% | 4.87% | 24.30% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
46 Neutral | ¥579.95B | 118.03 | -2.45% | 1.40% | 0.20% | 91.85% |